EMPAA L 25+5MG TAB 28sLinagliptin and Empagliflozin work together to lower blood sugar levels in individuals with type 2 diabetes. Linagliptin is a dipeptidyl peptidase 4 (DPP 4) inhibitor; it blocks the breakdown of incretin hormones, such as GLP 1 (glucagon like peptide 1), which stimulate insulin secretion and reduce glucagon secretion in a glucose dependent manner. This leads to increased insulin production and decreased glucagon release, resulting in better blood